with 30% of present valve insertions needing repeat procedures DurAVR at least could capture this segment of the market. The insurance companies would dictate that DurAVR be inserted de novo to avoid some of the replacement business in the future. The future looks rosy. Let an auction begin.
Ann: Update on DurAVR Valve-in-Valve Experience, page-4
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.90 |
Change
-0.900(7.63%) |
Mkt cap ! $230.4M | |||
| Open | High | Low | Value | Volume |
| $11.85 | $11.90 | $10.65 | $1.718M | 157.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $10.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.00 | 13000 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |